Regulatory 101: Drug Names – Reader Q&A

2021 ◽  
Vol 25 (3) ◽  
Author(s):  
Paul Pluta

Medication errors occur in writing, print, speaking, and electronic communications; all of these modes must be considered in development of the drug name. The perspectives of health professionals with product name usage on a daily basis is far different than that of industry personnel who develop drug names for product recognition and commercial marketing.

2018 ◽  
Vol 103 (2) ◽  
pp. e1.33-e1
Author(s):  
Patel Bhavee ◽  
Isaac Rachel ◽  
Vallabhaneni Pramodh

AimPaediatric medication errors have everyday potential to cause unintended harm.1 Our aim was to reduce paediatric medication errors on a busy general paediatric medical ward.MethodA prospective audit was undertaken, using an audit form, looking at the number and severity of medication errors from May 2016 to July 2016. The severity of the errors was graded as per the EQUIP study.2 The results were analysed using Microsoft Excel.Action – A study afternoon was arranged in August 2016 to highlight the common themes behind the medication errors followed by a multidisciplinary brainstorming exercise to gather suggestions on reducing medication errors.An education package was introduced:Medical – all trainees were asked to complete a mandatory online module designed by the Royal College of Paediatrics and Child Health, which provides an overview of need for safe prescription practice in children and common themes leading to errors. Further teaching was provided in departmental teaching meetings and the lead paediatric pharmacist undertook targeted teaching.Nursing – an in house competency package was developed based around the principles of the ‘5 rights’ of medication administration, the Health Board controlled drug policy and the All Wales Policy for Medicines Administration, Recording, Review, Storage and Disposal. All staff were encouraged to complete this package. Through one on one sessions with the practice development nurse, staff were coached to follow the five Rs of Right Drug, Right Dose, Right Time, Right Route, and Right Patient.Pharmacy – Lead pharmacist introduced an education tool as advocated by Meds IQ called Druggle3 in the department, where at the end of the safety huddle the pharmacist discusses medication interventions on a daily basis that may have happened on the ward. Through this tool formative education was provided to junior doctors and nurses.Re–audit – After six months of intensive education, a prospective re–audit was undertaken between December 2016 and February 2017 using an audit form. The results were analysed using Microsoft Excel.ResultsThe results showed that 88.6% (141/159) of children admitted had medication errors. 61.2% (87/141) of errors were minor, 34.7% (49/141) significant, 2.8% (4/141) serious and 1.3% (1/141) potentially lethal.The results of the re-audit showed that 12.1% (57/470) of children had medication errors. 77.2% (44/57) of errors were minor and 22.8% (13/57) significant. There were no serious or potentially lethal errors reported.This showed an overall reduction of 76.5% medication errors in the children admitted following the introduction of the education package.ConclusionThe education package through the tripartite approach has achieved a substantial change in the overall rate of prescription errors. We believe medication errors are a significant but preventable cause of harm to children and young people. To ensure this change of practice is sustained we aim to continue the emphasis of education and change management to improve patient safety.ReferencesCass H. Reducing paediatric medication error through quality improvement networks; where evidence meets pragmatism. Arch Dis Child2016;101:414–416.EQUIP final report. http://www.gmc-uk.org/FINAL_Report_prevalence_and_causes_of_prescribing_errors.pdf_28935150.pdf [Accessed: 01/08/16].DRUG-gle (Druggle). http://www.medsiq.org/tool/drug-gle-druggle [Accessed: 01/08/2016].


2011 ◽  
Vol 17 (2) ◽  
pp. 150 ◽  
Author(s):  
Jo Melville-Smith ◽  
Garth E. Kendall

Diabetes places a significant burden on the individuals concerned, their families and society as a whole. The debilitating sequelae of diabetes can be limited or prevented altogether through strict glycaemic control. Despite the seemingly uncomplicated nature of the disorder, effective management can be elusive, as the impact of having to deal with diabetes on a daily basis can be profound and appropriate professional support is not always readily available. As the roles of general practitioners (GPs) and allied health professionals have evolved, a major issue now facing all is that of developing and maintaining effective collaborative relationships for the facilitation of optimal community diabetes care. Using a simple survey methodology, the present exploratory study investigated the referral patterns of GPs to diabetic educators (DEs) working for a community health service in an Australian town, and reasons for referral and non-referral in order to identify factors that contribute to a sound and sustainable collaborative relationship. The results provide some evidence that GPs and DEs in this town do work collaboratively towards achieving client-centred goals and highlight the need to inform GPs who are new to communities, such as this one, of the available DE services. Most importantly, the study identified that there are many opportunities to strengthen collaboration so as to facilitate optimal community diabetes care. This information is valuable, because there is limited empirical evidence either nationally or internationally about the process of collaboration between health professionals in the management of chronic diseases, such as diabetes.


2021 ◽  
Vol 2021 ◽  
pp. 1-11
Author(s):  
Abdu Oumer ◽  
Ahmed Muhye ◽  
Imam Dagne ◽  
Nesredin Ishak ◽  
Ahmed Ale ◽  
...  

Background. A lot of effort is being done in the electronic medical record (EMR) system. However, it has not been implemented and used at the expected scale for maximal effectiveness. There is limited evidence on the factors affecting the utilization of EMR in this particular context, which are critical for targeted strategies. Objective. To assess the magnitude and factors affecting the utilization of EMR among health professionals in eastern Ethiopia. Methods. An institutional-based cross-sectional study was conducted among randomly selected 412 health professionals from Harari and Dire Dawa, eastern Ethiopia, using a pretested self-administered questionnaire. The tool was developed from previous literature, and a pilot survey was done before the actual study. Bivariable and multivariable binary logistic regression were done to assess the relationship between an independent variable with EMR use. Crude and an adjusted odds ratio with a 95% confidence interval were reported. A P value of less than 0.05 was used to declare a statistically significant association. Results. A total of 412 health professionals with a mean age of 29 years (±6.4 years) were included. A total of 229 (55.6%) and 300 (72.8%) of them had good knowledge and attitude towards the EMR, while 279 (67.7%) used the service (54% used it on a daily basis). About 272 (66%) of the respondents reported that they prefer EMRs to paper-based systems. Health professionals with more than five years of experience had two times higher odds of using the service ( AOR = 2.22 ; 95% CI; 1.12-4.42) than early-career workers. Health professionals trained in EMR would use the service more ( AOR = 5.88 ; 95% CI; 2.93-11.88) compared to those who did not take the training. In addition, having good knowledge ( AOR = 1.52 ; 95% CI; 0.92-1.5) and a good attitude towards the EMR system ( AOR = 2.4 ; 95% CI; 1.35-4.31) showed to use EMR as compared to counterparts. Conclusions. The utilization of EMR was found to be optimal. Age, work experience, knowledge, attitude, and training of professionals were positively associated with the use of the service in their facility.


1976 ◽  
Vol 10 (12) ◽  
pp. 698-702 ◽  
Author(s):  
Joseph L. Fink

The Poison Prevention Packaging Act of 1970 became effective on December 30, 1970, and its provisions and the enforcement efforts of the regulatory agencies charged with administering the Act have caused great consternation among both laymen and health professionals. An understanding of the social policy reflected by this legislation as well as the standards which have been promulgated for child-resistant packaging may go far to ameliorate the frustrations of those who have to deal with the requirements of the Act on a daily basis. A discussion of the historical evolution of the 1970 Act and the controversy surrounding it is followed by a review of the standards for child-resistant packaging and exemptions from the requirements of the Act. A discussion of physician and patient waivers focuses on the desirability of documentation. The role of the Act in a professional liability suit is anticipated. A list of the drugs which are currently under consideration for exemption is provided. A better understanding of this legislation should enable health professionals to better deal with their patients.


Author(s):  
Markus Reuber ◽  
Gregg H. Rawlings ◽  
Steven C. Schachter

This chapter describes the experience of an epilepsy nurse with patients with Non-Epileptic Attack Disorder (NEAD). It specifically details a rare case where the patient was undoubtedly diagnosed with NEAD and the diagnosis was met with complete acceptance. The patient was able to move forward with her life, putting this period of living with NEAD behind her, a period of time that possibly spanned several years. Ultimately, carers have a duty to provide ongoing support throughout the trajectory of the journey of patients with NEAD despite it being a psychiatric and not a neurological disorder. This condition if untreated or treated inappropriately can fundamentally affect quality of life on a daily basis, and health professionals all have a duty of care to address that.


2015 ◽  
Vol 5 (2) ◽  
pp. 110-117 ◽  
Author(s):  
Zaida Rahman ◽  
Rukhsana Parvin

The existence of confusing drug names is one of the most common causes of medication errors. There are many types of medication errors: wrong drug, wrong dose, wrong route of administration, wrong patient etc. Misreading medication names that look similar is a common mistake. These look-alike medication names may also sound alike and can lead to errors associated with verbal prescriptions. Similar sounding drugs may produce confusion and may lead to unintended interchange of drugs causing harm to patients or even patient death. The main aim of the study was to evaluate medication errors related to look alikesound alike drug names and to find out the strategies to prevent these medication errors.J Enam Med Col 2015; 5(2): 110-117


2020 ◽  
Vol 13 (9) ◽  
pp. 114
Author(s):  
K. D. Souza ◽  
D. P. M. Santin ◽  
S. F. Cetolin ◽  
V. Beltrame ◽  
L. P. Marmitt ◽  
...  

In December 2019, a new coronavirus was sparked in China, which was named the following year by the World Health Organization as Coronavirus Disease (COVID-19). The pandemic installed because to Covid-19 brought interference from social and governmental aspects, such as social isolation and the closing of borders, as strategies to reduce exposures of populations to the virus. In contrast, health professionals live a time of exposure and vulnerability, facing challenges on a daily basis. This paper aims to discuss the scenario of Covid-19 in Brazil and the challenges experienced by health professionals. This is a bibliographic review of complete scientific articles, published in the Scielo, BVS and WHO virtual libraries, between 2019 and 2020, in English or Portuguese languages, being articles in the Health Sciences area. Search for the keywords “coronavirus infections and healthcare personnel”, “coronavirus infections and Brazil”, and “coronavirus infections”. Were found 696 articles and 21 of relevant content were selected for the present review. Complementary official government data were also used. It is concluded that frontline health professionals in Brazil and other countries in the world face personal and professional challenges, related to degrading feelings, insufficient guidance on handling contaminated materials and practices with transitory truths and little scientific basis. It is observed the importance of professional valorization in typical days, bigger operational investments and care with the physical and mental health of the health professionals.


2020 ◽  
Vol 7 (1) ◽  
pp. 3
Author(s):  
Tewfik Said ◽  
Ahmad Almadani

Psychic pain goes far beyond the set of psychiatric symptoms that afflict our patients. Actually, there is much debate in our field as to what gives rise to the other; is psychic pain a by-product of psychiatric symptoms, such as depression and anxiety, or are symptoms a manifestation of psychic pain, namely that we develop symptoms by virtue that the psychic pain is unbearable. Although many of our therapeutic interventions tend to target symptom removal, or at least their alleviation, fewer efforts are placed on understanding the patients’ psychic pain. During this workshop "Beyond Psychiatric Symptoms", the presenters will give a brief outline of what we know about psychic pain and the challenge that is faced in reaching it. With extensive use of audiovisually recorded clinical interviews, we will expand on these concepts. A special emphasis will be placed on the training of health professionals to be able to identify, tolerate, and work with such pain on a daily basis. As this workshop will present vignettes of actual clinical interviews with patients, any form of recording or taking pictures throughout the presentation is absolutely forbidden to preserve patients’ confidentiality. 


Author(s):  
Renuka P. Munshi ◽  
Ganesh D. Tople ◽  
Sonali R. Munot

Background: With thousands of drugs currently in the market, the potential for medication errors due to confusing drug names amongst practising physicians, pharmacists and patients is significant. The existence of confusing drug names is one of the most common causes of medication error. There are many look-alikes, sound-alike (LASA) combinations that could potentially result in medication errors. There is insufficient data about medication errors due to LASA. Hence, we conducted the present study to determine the degree of awareness regarding LASA drugs among post graduate medical physicians and Pharmacists.Methods: This study was a cross-sectional, questionnaire-based survey, conducted among 137 year post graduate medical residents of a tertiary care teaching hospital and 121 local pharmacists in an urban metropolitan Indian city.Results: There were 34% resident doctors and 17% pharmacists were aware of concept of LASA drugs. Only 46% resident doctors and 22% pharmacists had knowledge about the full form of LASA. Among resident doctors, 39% came across prescription errors due to LASA drugs. Only 69% of the pharmacists agreed that they consulted their doctors when they faced problems due to prescription errors due to similar looking and similar sounding drugs.Conclusions: Look-Alike, Sound-Alike (LASA) drugs are common source of medication errors. Our study suggests that there is lack of awareness about LASA drugs amongst resident doctors and pharmacists, which may contribute to occurrence of medication errors. Therefore, combined efforts by prescribers, pharmacists, organizations, manufacturers and patients is required to overcome medication errors due to LASA drugs.


Sign in / Sign up

Export Citation Format

Share Document